ArticleAnnals of the American Thoracic Society2026
Impact of the COVID-19 pandemic on tuberculosis epidemiology in California, Florida, New York, and Texas.
Article in Annals of the American Thoracic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
rationaleThe United States experienced a considerable decline in tuberculosis (TB) incidence in 2020 following the COVID-19 pandemic.
objectivesWhile TB rates have since returned to near prepandemic levels, analyzing the pandemic's impact offers insight into TB epidemiology in the United States.
methodsFocusing on California, Florida, New York, and Texas-the 4 states with the highest TB incidence-we explored 3 potential mechanisms of pandemic-related disruption on TB epidemiology: (1) reduced immigration, (2) reduced Mtb transmission (through social distancing and other behavior changes), and (3) delays in care-seeking. We used data on the volume of nonimmigrant arrivals and new permanent residents, Google mobility and US transit data, and data on the volume of emergency department visits and cancer screenings to inform the magnitude of these effects at the state level, adapting previously developed state-specific transmission models. We then estimated the impact of each mechanism and projected future TB incidence through 2032. MEASUREMENTS AND MAIN
resultsDisruptions to migration and care-seeking across all 4 states were considerable but short-lasting, with 70% to 90% reductions in the first 4 months of the pandemic that returned to prepandemic levels by 2021. In contrast, transmission disruptions were moderate but more prolonged, with mobility still 10% to 20% lower than prepandemic in 2022. No statistical evidence was identified to favor models emphasizing immigration and transmission vs access to care.
conclusionsRevised projections for pandemic-related disruptions did not substantially differ from prepandemic projections beyond 2024. Future declines in TB incidence in the 4 states are likely to be small without additional interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.